Incyte Corporation (INCY)
NASDAQ: INCY · IEX Real-Time Price · USD
52.94
+0.89 (1.71%)
At close: May 1, 2024, 4:00 PM
52.84
-0.10 (-0.19%)
After-hours: May 1, 2024, 7:56 PM EDT
Incyte Revenue
Incyte had revenue of $3.77B in the twelve months ending March 31, 2024, with 8.58% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $880.89M with 8.93% year-over-year growth. In the year 2023, Incyte had annual revenue of $3.70B with 8.87% growth.
Revenue (ttm)
$3.77B
Revenue Growth
+8.58%
P/S Ratio
3.15
Revenue / Employee
$1,492,815
Employees
2,524
Market Cap
11.89B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.70B | 301.01M | 8.87% |
Dec 31, 2022 | 3.39B | 408.37M | 13.67% |
Dec 31, 2021 | 2.99B | 319.57M | 11.98% |
Dec 31, 2020 | 2.67B | 507.94M | 23.53% |
Dec 31, 2019 | 2.16B | 276.88M | 14.71% |
Dec 31, 2018 | 1.88B | 345.67M | 22.50% |
Dec 31, 2017 | 1.54B | 430.50M | 38.93% |
Dec 31, 2016 | 1.11B | 351.97M | 46.70% |
Dec 31, 2015 | 753.75M | 242.26M | 47.36% |
Dec 31, 2014 | 511.50M | 156.55M | 44.10% |
Dec 31, 2013 | 354.95M | 57.89M | 19.49% |
Dec 31, 2012 | 297.06M | 202.60M | 214.50% |
Dec 31, 2011 | 94.46M | -75.42M | -44.40% |
Dec 31, 2010 | 169.88M | 160.61M | 1,733.55% |
Dec 31, 2009 | 9.27M | 5.35M | 136.41% |
Dec 31, 2008 | 3.92M | -30.52M | -88.62% |
Dec 31, 2007 | 34.44M | 6.80M | 24.59% |
Dec 31, 2006 | 27.64M | 19.80M | 252.32% |
Dec 31, 2005 | 7.85M | -6.30M | -44.54% |
Dec 31, 2004 | 14.15M | -27.05M | -65.66% |
Dec 31, 2003 | 41.20M | -54.28M | -56.85% |
Dec 31, 2002 | 95.47M | -123.79M | -56.46% |
Dec 31, 2001 | 219.26M | 25.10M | 12.92% |
Dec 31, 2000 | 194.17M | 37.21M | 23.70% |
Dec 31, 1999 | 156.96M | 22.15M | 16.43% |
Dec 31, 1998 | 134.81M | 44.82M | 49.80% |
Dec 31, 1997 | 90.00M | 48.10M | 114.81% |
Dec 31, 1996 | 41.90M | 29.68M | 243.06% |
Dec 31, 1995 | 12.21M | 10.70M | 707.67% |
Dec 31, 1994 | 1.51M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Tenet Healthcare | 20.91B |
DaVita | 12.14B |
Solventum | 8.20B |
Charles River Laboratories International | 4.13B |
Exact Sciences | 2.50B |
United Therapeutics | 2.33B |
Medpace Holdings | 1.96B |
Insulet | 1.70B |
INCY News
- 1 day ago - Incyte misses quarterly profit on weak sales of lead drug - Reuters
- 1 day ago - Incyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs - Business Wire
- 8 days ago - Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists - Business Wire
- 20 days ago - Incyte to Report First Quarter Financial Results - Business Wire
- 4 weeks ago - Incyte and CMS Announce Collaboration and License Agreement for Povorcitinib, an Oral JAK1 Inhibitor, in Mainland China, Hong Kong, Macau, Taiwan and Southeast Asia - Business Wire
- 4 weeks ago - CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia - GlobeNewsWire
- 4 weeks ago - Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 7 weeks ago - The Stock Market Is Already Way Up. 8 Stocks That Can Still Outperform. - Barrons